However, the CD8+ T cell density was significantly higher (P=0.045, Figure 5C), indicating that RBM10 mutated patients recruited more T cells for tumor surveillance, while CD4+ T cell density presented no difference between RBM10 mutant and wild-type group (P=0.101, Figure 5D). The gene discussed is RBM10; the disease is neoplasm.